Susan W. Barnett

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

Zoe Moodie, Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe et autres

us, Afrique du Sud, Mozambique, Zimbabwe, be (code pays fourni par la source)

Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study

Beatriz Perdiguero, Benedikt Asbach, Carmen Gómez, Josef Köstler et autres

es, de, us, be, ch, gb (code pays fourni par la source)

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher, Mookho Malahleha et autres

Afrique du Sud, us, it, be, ch (code pays fourni par la source)

Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

Luca Schifanella, Susan W. Barnett, Massimiliano Bissa, Veronica Galli et autres

us (code pays fourni par la source)

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Xiaoying Shen, Fatima Laher, Zoe Moodie, Arthur S. McMillan et autres

us, Afrique du Sud, be (code pays fourni par la source)

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Mina C. Hosseinipour, Craig Innes, Sarita Naidoo, Philipp Mann et autres

us, Malawi, Afrique du Sud, Zambie, ch, be (code pays fourni par la source)

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

Luca Schifanella, Susan W. Barnett, Massimiliano Bissa, Veronica Galli et autres

us, se (code pays fourni par la source)

Zika virus infection of glia leads to secondary injury to axons and dendrites

Verena Schultz, Colin L. Crawford, Jennifer A. Barrie, Stephanie L. Cumberworth et autres

gb (code pays fourni par la source)

Correction for Kibler et al., “Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC”

Karen V. Kibler, Benedikt Asbach, Beatriz Perdiguero, Juan García‐Arriaza et autres

us, de, es, ch, gb (code pays fourni par la source)

Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period

Paul Spearman, Georgia D. Tomaras, David C. Montefiori, Ying Huang et autres

us (code pays fourni par la source)

Schifanella SHIVC All Data.xlsx

Luca Schifanella, Susan W. Barnett, Massimiliano Bissa, Veronica Galli et autres

Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC

Karen V. Kibler, Benedikt Asbach, Beatriz Perdiguero, Juan García‐Arriaza et autres

us, de, es, ch, gb (code pays fourni par la source)